January is Alzheimer Awareness Month in Canada, so we’re sharing some crucial information about the benefits of medical marijuana for Alzheimer patients.
Alzheimer’s is a progressive mental deterioration disease that can occur in middle or old age, due to generalized degeneration of the brain. It’s a form of dementia that effects memory, thinking and behaviour. Marijuana has long been studied and linked to be neuroprotective against the symptoms of Alzheimers, but new research on the plaque removal is pretty revolutionary in its findings. This landmark study proves that cannabinoids can fight both inflammation and amyloid beta accumulation in the brain’s cells.
Salk Institute scientists have found preliminary evidence that tetrahydrocannabinol (THC) and other compounds found in marijuana can promote the cellular removal of amyloid beta, a toxic protein associated with Alzheimer’s disease. The researchers found that high levels of amyloid beta were associated with cellular inflammation and higher rates of neuron death. They demonstrated that exposing the cells to THC reduced amyloid beta protein levels and eliminated the inflammatory response from the nerve cells caused by the protein, thereby allowing the nerve cells to survive. [Science Daily]
If you’re interested in learning about how medical marijuana can help with Alzheimer’s symptoms, please call us: 403-475-4205.